>There is a review article in the October issue of the journal Rheumatology covering successful and improving treatment of autoimmune diseases such as multiple sclerosis, Rheumatoid Arthritis, Lupus, and scleroderma. The abstract is free and (available here). About one third of the patients have gone into remission. The original 7% mortality rate has decreased to … Continue reading
There is a review article in the October issue of the journal Rheumatology covering successful and improving treatment of autoimmune diseases such as multiple sclerosis, Rheumatoid Arthritis, Lupus, and scleroderma. The abstract is free and (available here). About one third of the patients have gone into remission. The original 7% mortality rate has decreased to … Continue reading
>The agency that holds the patents on stem cells, WARF, has made a deal with the State of Wisconsin to wave the (disputed) patent licencing fees for companies in Wisconsin. The Governor of Wisconsin announced offerings of all sorts of deals to companies that move/start up in Wisconsin. Makes investment in embryonic stem cell research … Continue reading
The agency that holds the patents on stem cells, WARF, has made a deal with the State of Wisconsin to wave the (disputed) patent licencing fees for companies in Wisconsin. The Governor of Wisconsin announced offerings of all sorts of deals to companies that move/start up in Wisconsin. Makes investment in embryonic stem cell research … Continue reading